{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T01:02:23Z","timestamp":1789693343217,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T00:00:00Z","timestamp":1487289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Whether or not esophagogastric varices (EGV) could determine the outcomes of patients with hepatocellular carcinoma (HCC) is still unclear. A total of 990 treatment-naive HCC patients who received an esophagogastroduodenoscopy at the time of HCC diagnosis were retrospectively enrolled. The factors in terms of prognosis were analyzed by Cox proportional hazards model and propensity score matching analysis. Among the enrolled patients, 480 (48.5%) patients had EGV. Patients with EGV had a significantly lower cumulative 5-year survival rate than those without EGV (24.9% versus 46.4%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). It was confirmed by a multivariate analysis and propensity score matching analysis. Stratified by tumor stage, the patients with EGV had lower survival rates than the patients without EGVs in all Barcelona Clinic Liver Cancer stages except stage D. Moreover, the patients with EGV had lower survival rates than those without EGV, both by curative or non-curative treatment modalities. In conclusion, EGV was an independent risk factor predicting poor prognosis for the patients with HCC by multivariate analysis, propensity score matching analysis, and subgroup analysis.<\/jats:p>","DOI":"10.1038\/srep42577","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T10:08:22Z","timestamp":1487326102000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma"],"prefix":"10.1038","volume":"7","author":[{"given":"Wei-Yao","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yee-","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"BFsrep42577_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag, H. B. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142, 1264\u20131273; doi: 10.1053\/j.gastro.2011.12.061 (2012).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2015. CA Cancer J Clin 65, 5\u201329; doi: 10.3322\/caac.21254 (2015).","journal-title":"CA Cancer J Clin"},{"key":"BFsrep42577_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2011.05.026","volume":"56","author":"V Santi","year":"2012","unstructured":"Santi, V. et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. J Hepatol 56, 397\u2013405; doi: 10.1016\/j.jhep.2011.05.026 (2012).","journal-title":"J Hepatol"},{"key":"BFsrep42577_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.24710","volume":"55","author":"SF Altekruse","year":"2012","unstructured":"Altekruse, S. F., McGlynn, K. A., Dickie, L. A. & Kleiner, D. E. Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, 1992\u20132008. Hepatology 55, 476\u2013482; doi: 10.1002\/hep.24710 (2012).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000367727","volume":"4","author":"M Kudo","year":"2015","unstructured":"Kudo, M. Surveillance, diagnosis, treatment, and outcome of liver cancer in Japan. Liver Cancer 4, 39\u201350; doi: 10.1159\/000367727 (2015).","journal-title":"Liver Cancer"},{"key":"BFsrep42577_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/liv.12960","volume":"36","author":"SY Yim","year":"2016","unstructured":"Yim, S. Y. et al. The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years? Liver Int 36, 445\u2013453; doi: 10.1111\/liv.12960 (2016).","journal-title":"Liver Int"},{"key":"BFsrep42577_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.gastro.2013.03.051","volume":"145","author":"JC Nault","year":"2013","unstructured":"Nault, J. C. et al. A hepatocellular carcinoma 5-gene score associated with survival of patients after liver resection. Gastroenterology 145, 176\u2013187; doi: 10.1053\/j.gastro.2013.03.051 (2013).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR8","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1245\/s10434-014-4221-5","volume":"22","author":"CW Su","year":"2015","unstructured":"Su, C. W. et al. Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection. Ann Surg Oncol 22, 2253\u20132261; doi: 10.1245\/s10434-014-4221-5 (2015).","journal-title":"Ann Surg Oncol"},{"key":"BFsrep42577_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.27431","volume":"61","author":"A Berzigotti","year":"2015","unstructured":"Berzigotti, A., Reig, M., Abraldes, J. G., Bosch, J. & Bruix, J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61, 526\u2013536; doi: 10.1002\/hep.27431 (2015).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR10","doi-asserted-by":"publisher","first-page":"e66457","DOI":"10.1371\/journal.pone.0066457","volume":"8","author":"CW Su","year":"2013","unstructured":"Su, C. W. et al. The influence of hepatitis B viral load and pre-S deletion mutations on post-operative recurrence of hepatocellular carcinoma and the tertiary preventive effects by anti-viral therapy. PLoS One 8, e66457; doi: 10.1371\/journal.pone.0066457 (2013).","journal-title":"PLoS One"},{"key":"BFsrep42577_CR11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/hep.25950","volume":"57","author":"CY Hsu","year":"2013","unstructured":"Hsu, C. Y. et al. Performance status in patients with hepatocellular carcinoma: determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology 57, 112\u2013119; doi: 10.1002\/hep.25950 (2013).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR12","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1245\/s10434-011-1551-4","volume":"18","author":"D D\u2019Avola","year":"2011","unstructured":"D\u2019Avola, D. et al. Prognosis of hepatocellular carcinoma in relation to treatment across BCLC stages. Ann Surg Oncol 18, 1964\u20131971; doi: 10.1245\/s10434-011-1551-4 (2011).","journal-title":"Ann Surg Oncol"},{"key":"BFsrep42577_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/apt.13505","volume":"43","author":"M Walker","year":"2016","unstructured":"Walker, M. et al. Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer. Aliment Pharmacol Ther 43, 621\u2013630; doi: 10.1111\/apt.13505 (2016).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep42577_CR14","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.jhep.2012.07.038","volume":"57","author":"PH Chen","year":"2012","unstructured":"Chen, P. H. et al. Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol 57, 1207\u20131213; doi: 10.1016\/j.jhep.2012.07.038 (2012).","journal-title":"J Hepatol"},{"key":"BFsrep42577_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2013.10.018","volume":"146","author":"E Reverter","year":"2014","unstructured":"Reverter, E. et al. A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology 146, 412\u2013419; doi: 10.1053\/j.gastro.2013.10.018 (2014).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R de Franchis","year":"2015","unstructured":"de Franchis, R. & Baveno, V. I. F. Expanding consensus in portal hypertension: Report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol 63, 743\u2013752; doi: 10.1016\/j.jhep.2015.05.022 (2015).","journal-title":"J Hepatol"},{"key":"BFsrep42577_CR17","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.cgh.2015.07.012","volume":"13","author":"G Garcia-Tsao","year":"2015","unstructured":"Garcia-Tsao, G. & Bosch, J. Varices and variceal hemorrhage in cirrhosis: A new view of an old problem. Clin Gastroenterol Hepatol 13, 2109\u20132117; doi: 10.1016\/j.cgh.2015.07.012 (2015).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFsrep42577_CR18","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cgh.2006.08.011","volume":"4","author":"EG Giannini","year":"2006","unstructured":"Giannini, E. G. et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol 4, 1378\u20131384; doi: 10.1016\/j.cgh.2006.08.011 (2006).","journal-title":"Clin Gastroenterol Hepatol"},{"key":"BFsrep42577_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/apt.13485","volume":"43","author":"L Bucci","year":"2016","unstructured":"Bucci, L. et al. Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatment and outcome. Aliment Pharmacol Ther 43, 385\u2013399; doi: 10.1111\/apt.13485 (2016).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep42577_CR20","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s00268-015-3110-9","volume":"39","author":"N Harada","year":"2015","unstructured":"Harada, N. et al. Surgical resection for hepatocellular carcinoma with concomitant esophageal varices. World J Surg 39, 2510\u20132518; doi: 10.1007\/s00268-015-3110-9 (2015).","journal-title":"World J Surg"},{"key":"BFsrep42577_CR21","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","volume":"134","author":"T Ishizawa","year":"2008","unstructured":"Ishizawa, T. et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134, 1908\u20131916; doi: 10.1053\/j.gastro.2008.02.091 (2008).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.dld.2011.03.002","volume":"43","author":"C Merkel","year":"2011","unstructured":"Merkel, C. & Montagnese, S. Hepatic venous pressure gradient measurement in clinical hepatology. Dig Liver Dis 43, 762\u2013767; doi: 10.1016\/j.dld.2011.03.002 (2011).","journal-title":"Dig Liver Dis"},{"key":"BFsrep42577_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/apt.12721","volume":"39","author":"G D\u2019Amico","year":"2014","unstructured":"D\u2019Amico, G. et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 39, 1180\u20131193; doi: 10.1111\/apt.12721 (2014).","journal-title":"Aliment Pharmacol Ther"},{"key":"BFsrep42577_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix, J. & Sherman, M. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020\u20131022; doi: 10.1002\/hep.24199 (2011).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.gastro.2012.10.001","volume":"144","author":"A Berzigotti","year":"2013","unstructured":"Berzigotti, A. et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology 144, 102\u2013111; doi: 10.1053\/j.gastro.2012.10.001 (2013).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/hep.21941","volume":"47","author":"AA Qamar","year":"2008","unstructured":"Qamar, A. A. et al. Platelet count is not a predictor of the presence or development of gastroesophageal varices in cirrhosis. Hepatology 47, 153\u2013159; doi: 10.1002\/hep.21941 (2008).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR27","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1056\/NEJMoa044456","volume":"353","author":"RJ Groszmann","year":"2005","unstructured":"Groszmann, R. J. et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 353, 2254\u20132261; doi: 10.1056\/NEJMoa044456 (2005).","journal-title":"N Engl J Med"},{"key":"BFsrep42577_CR28","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis, E. A., Bosch, J. & Burroughs, A. K. Liver cirrhosis. Lancet 383, 1749\u20131761; doi: 10.1016\/S0140-6736(14)60121-5 (2014).","journal-title":"Lancet"},{"key":"BFsrep42577_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jhep.2015.08.025","volume":"64","author":"A Cucchetti","year":"2016","unstructured":"Cucchetti, A. et al. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma. J Hepatol 64, 79\u201386; doi: 10.1016\/j.jhep.2015.08.025 (2016).","journal-title":"J Hepatol"},{"key":"BFsrep42577_CR30","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","volume":"150","author":"J Bruix","year":"2016","unstructured":"Bruix, J., Reig, M. & Sherman, M. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma. Gastroenterology 150, 835\u2013853; doi: 10.1053\/j.gastro.2015.12.041 (2016).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR31","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56, 908\u2013943; doi: 10.1016\/j.jhep.2011.12.001 (2012).","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"BFsrep42577_CR32","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/hep.510300629","volume":"30","author":"JM Llovet","year":"1999","unstructured":"Llovet, J. M., Fuster, J. & Bruix, J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30, 1434\u20131440; doi: 10.1002\/hep.510300629 (1999).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR33","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","volume":"111","author":"J Bruix","year":"1996","unstructured":"Bruix, J. et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111, 1018\u20131022 (1996).","journal-title":"Gastroenterology"},{"key":"BFsrep42577_CR34","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","volume":"250","author":"A Cucchetti","year":"2009","unstructured":"Cucchetti, A. et al. Is portal hypertension a contraindication to hepatic resection? Ann Surg 250, 922\u2013928; doi: 10.1097\/SLA.0b013e3181b977a5 (2009).","journal-title":"Ann Surg"},{"key":"BFsrep42577_CR35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hep.27745","volume":"62","author":"S Roayaie","year":"2015","unstructured":"Roayaie, S. et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62, 440\u2013451; doi: 10.1002\/hep.27745 (2015).","journal-title":"Hepatology"},{"key":"BFsrep42577_CR36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/j.1477-2574.2012.00594.x","volume":"15","author":"R Santambrogio","year":"2013","unstructured":"Santambrogio, R. et al. Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh\u2019s A cirrhosis: is clinical evidence of portal hypertension a contraindication? HPB (Oxford) 15, 78\u201384; doi: 10.1111\/j.1477-2574.2012.00594.x (2013).","journal-title":"HPB (Oxford)"},{"key":"BFsrep42577_CR37","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12072-010-9213-3","volume":"4","author":"HH Hung","year":"2010","unstructured":"Hung, H. H. et al. Fibrosis and AST to platelet ratio index predict post-operative prognosis for solitary small hepatitis B-related hepatocellular carcinoma. Hepatol Int 4, 691\u2013699; doi: 10.1007\/s12072-010-9213-3 (2010).","journal-title":"Hepatol Int"},{"key":"BFsrep42577_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1572-0241.2001.03627.x","volume":"96","author":"MR Arguedas","year":"2001","unstructured":"Arguedas, M. R., McGuire, B. M., Fallon, M. B. & Abrams, G. A. The use of screening and preventive therapies for gastroesophageal varices in patients referred for evaluation of orthotopic liver transplantation. Am J Gastroenterol 96, 833\u2013837; doi: 10.1111\/j.1572-0241.2001.03627.x (2001).","journal-title":"Am J Gastroenterol"},{"key":"BFsrep42577_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00004836-200301000-00018","volume":"36","author":"K Matsunaga","year":"2003","unstructured":"Matsunaga, K. et al. Endoscopic injection sclerotherapy for esophageal varices in cirrhotic patients with hepatocellular carcinoma: risk factors for survival. J Clin Gastroenterol 36, 68\u201371 (2003).","journal-title":"J Clin Gastroenterol"},{"key":"BFsrep42577_CR40","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1007\/s10620-016-4255-6","volume":"61","author":"JH Kim","year":"2016","unstructured":"Kim, J. H. et al. Primary prophylaxis for variceal bleeding and the improved survival of patients with newly diagnosed hepatocellular carcinoma. Dig Dis Sci 61, 3354\u20133362; doi: 10.1007\/s10620-016-4255-6 (2016).","journal-title":"Dig Dis Sci"},{"issue":"1","key":"BFsrep42577_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","volume":"9","author":"Hung\u2013Hsu Hung","year":"2011","unstructured":"Hung, H. H. et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin Gastroenterol Hepatol 9, 79\u201386; doi: 10.1016\/j.cgh.2010.08.018.","journal-title":"Clinical Gastroenterology and Hepatology"},{"key":"BFsrep42577_CR42","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S1665-2681(19)31365-1","volume":"12","author":"PH Chen","year":"2013","unstructured":"Chen, P. H. et al. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation. Ann Hepatol 12, 263\u2013273 (2013).","journal-title":"Ann Hepatol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42577","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42577.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:16:00Z","timestamp":1671826560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,3,14]]}},"alternative-id":["BFsrep42577"],"URL":"https:\/\/doi.org\/10.1038\/srep42577","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"assertion":[{"value":"29 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42577"}}